Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 30;19(10):90.
doi: 10.1007/s11892-019-1217-3.

Medical Devices in Obesity Treatment

Aruchuna Ruban  1 , Akash Doshi  2 , Erika Lam  2 , Julian P Teare  3
Affiliations
Review

Medical Devices in Obesity Treatment

Aruchuna Ruban et al. Curr Diab Rep. .

Abstract

Purpose of review: Obesity is increasing at an alarming rate and now poses a global threat to humankind. In recent years, we have seen the emergence of medical devices to combat the obesity epidemic. These therapeutic strategies are discussed in this review dividing them into gastric and duodenal therapies.

Recent findings: Traditionally, medical devices for obesity such as the intragastric balloon have focused on reducing gastric size, but more recently there has been a shift towards developing devices that modulate neural and hormonal responses to induce early satiety thus reducing oral intake. Medical devices for obesity treatment may have a role in those patients who are struggling to control their weight despite significant lifestyle modifications such as diet and exercise and who decline or are unfit for bariatric surgery. For the wider adoption and integration of these devices in the obesity treatment paradigm, more long-term efficacy and safety data from randomised controlled trials are required.

Keywords: Bariatric surgery; Body mass index; Duodenal; Endoscopy; Gastric; Obesity; Weight loss.

PubMed Disclaimer

Conflict of interest statement

Aruchuna Ruban and Julian P. Teare report personal fees from GI Dynamics.

Akash Doshi and Erika Lam declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
AspireAssist® device. (With permission from Aspire Bariatrics, Inc.)
See this image and copyright information in PMC

References

    1. WHO, Obesity and overweight. 2015. Factsheet No.31.
    1. Tobias DK, Pan A, Jackson CL, O'Reilly EJ, Ding EL, Willett WC, Manson JAE, Hu FB. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370(3):233–244. - PMC - PubMed
    1. Lee CM, et al. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008;61(7):646–653. - PubMed
    1. Ogden CL, Carroll MD, Flegal KM. Prevalence of obesity in the United States Letters. JAMA. 2014;312(2):189–190. - PubMed
    1. Pigeyre M, Yazdi FT, Kaur Y, Meyre D. Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity. Clin Sci. 2016;130(12):943–986. - PubMed